Xeomin 100 LD50-Einheiten
As listed in the register: Xeomin 100 LD50-Einheiten, Pulver zur Herstellung einer Injektionslösung
·
- Prescription only
- Muscles, joints and bones
- Active substance
- Toxinum botulinicum A (150 kDa)
- Used in
- Muscles, joints and bones
- Made by
- Merz Pharma (Schweiz) AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Bei Erwachsenen zur symptomatischen Behandlung von Blepharospasmus, zervikaler Dystonie mit überwiegend rotatorischer Komponente (Torticollis spasmodicus), fokaler Spastik der oberen und unteren Extremitäten, chronischer, beeinträchtigender Sialorrhö. Bei Kindern und Jugendlichen im Alter von 2 bis 17 Jahren zur symptomatischen Behandlung von chronischer, beeinträchtigender Sialorrhoe aufgrund neurologischer Erkrankungen / Entwicklungsstörungen.
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Merz Pharma (Schweiz) AG |
|---|---|
| Active substance | Toxinum botulinicum A (150 kDa) |
| Used in | Muscles, joints and bones |
| Classification | M03AX01 · Muscles, joints and bones |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Xeomin 100 LD50-Einheiten, Pulver zur Herstellung einer Injektionslösung |
| Packs | 1 Durchstechflasche(n) |
| Zulassungsnummer | 62080 |
| Dosisstärke | 2 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.